MAPT and Alzheimer disease: By using this approach, we take a significant step towards understanding the neuronal arm of AD pathogenesis: we identify perturbations in DEK as a novel molecular bridge between a wide range of processes that take place during early stages of AD: dysregulation of neuronal excitability, tau accumulation and alterations in microglia activity (Supplementary Fig. 7).